Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totaling 8,630 shares, a decrease of 75.5% from the December 15th total of 35,213 shares. Approximately 1.0% of the company’s stock are short sold. Based on an average daily volume of 26,165 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 26,165 shares, the short-interest ratio is currently 0.3 days. Approximately 1.0% of the company’s stock are short sold.
Virtus LifeSci Biotech Clinical Trials ETF Stock Performance
BBC stock opened at $39.01 on Tuesday. The firm has a 50 day simple moving average of $36.76 and a 200 day simple moving average of $28.87. Virtus LifeSci Biotech Clinical Trials ETF has a 52 week low of $13.42 and a 52 week high of $40.82.
About Virtus LifeSci Biotech Clinical Trials ETF
Read More
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
